Baolingbao Biology Co.,Ltd.

SZSE:002286.SZ

7.46 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 2,523.9142,712.7452,764.9772,054.5781,805.171,730.0121,592.9961,377.4241,196.282910.71900.769978.028950.773720.615525.4536.555414.326257.343
Cost of Revenue 2,319.3822,399.9322,394.7891,866.4751,537.1251,487.8291,379.511,171.7051,032.024801.875764.043776.735747.675579.629411.652410.33305.046188.805
Gross Profit 204.532312.813370.188188.104268.045242.183213.486205.719164.258108.836136.727201.293203.098140.987113.747126.225109.27968.538
Gross Profit Ratio 0.0810.1150.1340.0920.1480.140.1340.1490.1370.120.1520.2060.2140.1960.2160.2350.2640.266
Reseach & Development Expenses 11.2998.4612.58111.29.1194.5395.02615.7326.25610.94813.1326.55.954.2040000
General & Administrative Expenses 14.29926.71427.58315.27712.88815.6679.45512.5957.7427.7019.41611.7920.9747.84925.11925.61314.99110.067
Selling & Marketing Expenses 35.76736.79433.90931.801114.204111.856102.2796.42989.1162.54857.61367.71473.41443.50421.14419.2916.8589.352
SG&A 50.06763.50861.49247.078127.093127.523111.725109.02496.85170.24967.02879.50494.38851.35246.26344.90431.84919.42
Other Expenses 1.10773.22663.89257.17556.302-2.41-0.8068.9610.8214.55918.3248.6044.6929.03610.5714.0752.7820.024
Operating Expenses 112.458145.194137.966115.453192.513170.674156.873168.314138.656111.516110.836119.243130.86579.49648.78248.62433.78120.283
Operating Income 64.008160.23235.9360.73685.33154.07357.89549.736.75413.93930.68871.11261.25941.54935.74849.01249.45531.319
Operating Income Ratio 0.0250.0590.0850.030.0470.0310.0360.0360.0310.0150.0340.0730.0640.0580.0680.0910.1190.122
Total Other Income Expenses Net 1.107-3.540.807-1.104-39.544-19.0090.47521.02122.20730.03523.122-2.334-6.282-10.906-18.647-24.513-23.261-16.912
Income Before Tax 65.115156.69236.73759.63245.78752.557.08958.42547.80927.35449.01379.71665.95150.58446.31853.08752.23731.343
Income Before Tax Ratio 0.0260.0580.0860.0290.0250.030.0360.0420.040.030.0540.0820.0690.070.0880.0990.1260.122
Income Tax Expense 11.14623.52135.1589.7710.8629.8587.9929.2226.8633.4317.08312.39410.2347.787.0458.3118.9411.336
Net Income 53.969133.169201.57949.86235.23442.95349.62249.34340.94623.92241.93167.32655.72242.80539.27444.77733.29620.008
Net Income Ratio 0.0210.0490.0730.0240.020.0250.0310.0360.0340.0260.0470.0690.0590.0590.0750.0830.080.078
EPS 0.150.360.550.140.0950.120.130.130.110.060.120.260.210.160.230.220.190.2
EPS Diluted 0.150.360.550.140.0950.120.130.130.110.060.120.260.210.160.230.220.190.2
EBITDA 223.331288.332351.84169.426183.561172.166143.457146.501115.39182.573104.018136.537118.19100.442106.423106.49691.39860.366
EBITDA Ratio 0.0880.1060.1270.0820.1020.10.090.1060.0960.0910.1150.140.1240.1390.2030.1980.2210.235